AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Agilent Presents Thought Leader Award to Professor Diether Lambrechts

February 20, 2019

SANTA CLARA, Calif.--(BUSINESS WIRE)--Feb 20, 2019--Agilent Technologies Inc. (NYSE: A) today announced that Professor Diether Lambrechts has received an Agilent Thought Leader Award in support of his research in cancer genomics.

Dr. Lambrechts directs the VIB-KU Leuven Center for Cancer Biology in Leuven, Belgium. He is also a professor of human genetics at KU Leuven. Dr. Lambrechts lab focuses on the discovery of genetic or epigenetic markers, either as susceptibility factors for cancer treatment development, as prognostic markers to improve the molecular genetic annotation of cancer, or as markers for targeted cancer therapies.

“Agilent continues to support transformative research of leading academic researchers—in this case, to advance our understanding of the mechanisms of resistance of tumor cells to immunotherapy,” said Kamni Vijay, Agilent vice president, and general manager of the company’s Genomics Division. “Dr. Lambrechts’ research has the potential to identify biomarkers as well as alternative drug targets. He and his team may also be able to show the way toward new companion diagnostics to help oncologists more accurately match patients with the best available treatment.”

“I am thrilled to receive this award from Agilent. This kind of support is essential to advance cancer research and discover novel biomarkers for checkpoint immunotherapy in cancer patients,” said Dr. Lambrechts. “Cancer immunotherapy has created a paradigm shift in the treatment of advanced-stage cancers, but it only delivers durable clinical responses in a relatively small fraction of cancer patients. By applying a combination of single-cell profiling methods we hope to have a major impact on patients receiving these therapies.”

The Agilent Thought Leader Award promotes fundamental scientific advances by contributing financial support, products, and expertise to the research of influential thought leaders in the life sciences, diagnostics and chemical analysis space. Information about previous award recipients is available on the Agilent Thought Leader Award webpage.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers’ most challenging questions. The company generated revenues of $4.91 billion in fiscal 2018 and employs 14,800 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to our Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190220005624/en/

CONTACT: Naomi Goumillout

Agilent Technologies

+1.781.266.2819

naomi.goumillout@agilent.com

KEYWORD: UNITED STATES BELGIUM EUROPE NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: TECHNOLOGY SOFTWARE HEALTH BIOTECHNOLOGY CLINICAL TRIALS GENETICS ONCOLOGY RESEARCH SCIENCE

SOURCE: Agilent Technologies Inc.

Copyright Business Wire 2019.

PUB: 02/20/2019 11:00 AM/DISC: 02/20/2019 11:01 AM

http://www.businesswire.com/news/home/20190220005624/en